Directorate Change
Non-Executive Director Tracey James resigned with immediate effect; search underway for replacement and new Non-Executive Chair.
Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that the Company has received notice of resignation from Tracey James as Non-Executive Director of the Board with immediate effect. The Company can confirm that Ms James' decision to resign from the Board is unrelated to the Company's financial performance or outlook. The Company's trading update for H1 2025 will be issued on 22 July 2025 as previously announced.
The Nominations Committee has commenced a process to appoint a new independent Non-Executive Director and the Company will announce the results of this process in due course.
Separately, the Nominations Committee is progressing well in its process to appoint a new independent Non-Executive Chair, a further announcement will be made in due course.
| Peel Hunt LLP (Joint Broker) | +44 (0)20 7418 8900 |
| James Steel, Dr Christopher Golden | |
| Davy (Joint Broker) | +353 (0) 1 679 6363 |
| Anthony Farrell, Niall Gilchrist | |
| Walbrook PR (Financial PR & IR) Paul McManus / Alice Woodings Lianne Applegarth | +44 (0)20 7933 8780 or hvivo@walbrookpr.com +44 (0)7980 541 893 / +44 (0)7407 804 654 +44 (0)7584 391 303 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.